Sildenafil Citrate Tablet, Film Coated
Product Images NDC 71205-305

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 71205-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-305-30 (Sildenafil Tablets Usp 20mg 90 Label)

This is a description of a medication called Sildenafil 20mg. It comes in a bottle with lot number 00000 and an expiration date of 00100100. The bottle has the product ID QS030530 and the manufacturer is Rubicon Research Private Limited in India. The medication contains Sildenafil Citrate equivalent to 20 mg sildenafil and is a white round, biconvex film coated tablet with "R" on one side and "20" on the other. It is for prescription use only and should be stored between 20°-25°C (68°-77°F) away from children.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 06)

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 07)

This text appears to be a table listing various drugs and their recommended dose adjustments based on their effects on AUC and Cmax values. It also mentions the lack of exercise capacity benefits when Silenafil is added to Bosentan therapy.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 08)

This is a drug interaction table showing drugs that interact with Acenocoumarol. The table provides recommendations for dose adjustment of the interacting drug based on fold change and 90% confidence interval (CI) of various parameters such as INR AUC, INR Cmax, BT, AUC, and Cmax. There is a note indicating that the co-administration of Doxazosin and Saquinavir with Acenocoumarol is not recommended, and the addition of Sildenafil to Bosentan therapy may not benefit exercise capacity. Another note highlights the effect of Ritonavir on Sildenafil PK.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 09)

The text displays the change from baseline in meters for different amounts of Sildenafil dosages in weeks 4, 8, and 12 of a study. The dosages mentioned are 20mg, 40mg, and 80mg TID. No additional data is available to provide further clarity.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 10)

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 11)

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 12)

The provided text contains some numerical values and incomplete information about a medical study comparing the effects of different doses of Sildenafil. It includes a plot that represents the mean change in meters from the baseline, accompanied by standard error bars for each treatment at every visit up to week 12. No further information is provided on the study design, participants, or outcomes to draw any conclusions or analysis.*

FDA Label Image

Structure Formula (Sildenafil Tablets Usp 20mg Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.